http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-069356-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81ad53b64eb74859acdc01278829b080 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L23-00 |
| filingDate | 2008-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91565e4a4a636eac3b518542449d1f3c |
| publicationDate | 2010-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-069356-A1 |
| titleOfInvention | ORAL FARINGEA DYSPHAGIA TREATMENT |
| abstract | Claim 1: An orally administrable liquid nutritional or medicinal product characterized in that it comprises: at least one vanilloid receptor agonist 1 (VR-1) capable of promoting a swallowing reflex in an individual. Claim 2: An orally administrable liquid hydration product characterized in that it comprises: at least one vanilloid receptor agonist 1 (VR-1) capable of promoting a swallowing reflex in an individual. Claim 3: A modified textured food product characterized in that it comprises: at least one vanilloid receptor agonist 1 (VR-1) capable of promoting a swallowing reflex in an individual. Claim 4: The product of claim 1, 2, or 3, characterized in that at least one VR-1 agonist is not pungent. Claim 5: The product of claim 1, 2, or 3, characterized in that at least one VR-1 agonist is selected from the group consisting of: capsaicin, capsiate, dihydrocapsaicin, nordihydrocapssate dihydrocapsiate, nordihydrocapsiate, homocapsaicin, vanodine homosacid, homodihydride n-nonanoic acid (VNA), anandamide, resiniferatoxin and olvanyl. Claim 6: The product of claim 1, 2, or 3, characterized in that it further comprises at least one of the following: a protein, a soluble fiber, an insoluble fiber, a fatty acid, a vitamin, a mineral, a sugar, a carbohydrate, a flavoring agent, a medicine and a therapeutic agent. |
| priorityDate | 2007-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.